Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)

NCT04627428 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Luxa Biotechnology, LLC

Collaborators